🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific action to tackle household expense challenges" in the forthcoming financial statement.

During an interview with media outlets, she stated that curbing price rises is a collective duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the G7 industrialized countries this calendar year and next.

Possible Utility Bill Measures

It is understood the government could take action to bring down energy bills, for example by slashing the present 5% rate of VAT applied on energy.

Another possibility is to cut some of the regulatory levies presently added to bills.

Fiscal Limitations and Expert Expectations

The administration will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much scope there is for these actions.

The view from most analysts is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Earlier on Thursday, estimates showed there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of expectations.

"It is a collective job between the central bank and the administration to continue tackling some of the drivers of inflation," Reeves told reporters in Washington, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to raise tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with increasing geopolitical and trade concerns for the fiscal tax moves, likely to be targeted on those "wealthiest."

International Economic Tensions

Referring to apprehensions about the UK's commercial links with China she said: "The UK's national security always come first."

Recent declaration by China to increase export controls on critical minerals and other resources that are essential for advanced tech manufacturing led US President the US President to threaten an additional 100% tariff on imports from the Asian country, raising the possibility of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary called China's action "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "very concerned" by China's actions and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "bad for the international commerce and generates further headwinds."

"I believe there are areas where we need to challenge Chinese policies, but there are also significant opportunities to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to achieve that equilibrium right."

The chancellor also affirmed she was cooperating with international partners "regarding our own essential resources strategy, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the cost the National Health Service spends on drugs could rise as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and investment.

Some of the biggest global drug companies have said in recent statements that they are either halting or canceling investments in the United Kingdom, with some blaming the low prices they are getting.

Last month, the government science advisor said the cost the health service spends on medicines would have to rise to stop companies and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "It has been observed as a result of the cost structure, that drug testing, innovative medicines have not been offered in the UK in the extent that they are in other continental states."

"Our aim is to make sure that patients getting treatment from the NHS are can receive the best essential medicines in the world. And so we are looking at all of that, and... seeking to attract additional capital into the UK."